124 related articles for article (PubMed ID: 9972056)
1. Prolidase as a prodrug converting enzyme. II. Synthesis of proline analogue of anthraquinone-2-carboxylic acid and its susceptibility to the action of prolidase.
Bielawska A; Bielawski K; Pałka J
Rocz Akad Med Bialymst; 1998; 43():201-9. PubMed ID: 9972056
[TBL] [Abstract][Full Text] [Related]
2. Prolidase as a prodrug converting enzyme I. Synthesis of proline analogue of chlorambucil and its susceptibility to the action of prolidase.
Bielawska A; Bielawski K; Pałka J
Rocz Akad Med Bialymst; 1997; 42(1):148-55. PubMed ID: 9581474
[TBL] [Abstract][Full Text] [Related]
3. Prolidase as a prodrug converting enzyme. III. Synthesis of proline analogues of melphalan and theirs susceptibility to the action of prolidase.
Bielawska A; Bielawski K; Pałka J
Rocz Akad Med Bialymst; 1999; 44():190-9. PubMed ID: 10697434
[TBL] [Abstract][Full Text] [Related]
4. Prolidase, a potential enzyme target for melanoma: design of proline-containing dipeptide-like prodrugs.
Mittal S; Song X; Vig BS; Landowski CP; Kim I; Hilfinger JM; Amidon GL
Mol Pharm; 2005; 2(1):37-46. PubMed ID: 15804176
[TBL] [Abstract][Full Text] [Related]
5. Decreased cytotoxicity and increased antimitotic activity of a proline analogue of chlorambucil as a prodrug susceptible to the action of fibroblast's prolidase.
Bielawska A; Chrzanowski K; Bielawski K; Pałka J
Pharmazie; 2001 Apr; 56(4):290-4. PubMed ID: 11338665
[TBL] [Abstract][Full Text] [Related]
6. Proline analogue of melphalan as a prodrug susceptible to the action of prolidase in breast cancer MDA-MB 231 cells.
Chrzanowski K; Bielawska A; Pałka J
Farmaco; 2003 Nov; 58(11):1113-9. PubMed ID: 14572862
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity activity of L-proline analogues of anthraquinone-2-carboxylic acid in breast cancer MCF-7 cells.
Bielawska A; Bielawski K; Pałka J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():207-8. PubMed ID: 11820611
[TBL] [Abstract][Full Text] [Related]
8. Proline analogue of melphalan as a prolidase-convertible pro-drug in breast cancer MCF-7 cells.
Chrzanowski K; Pałka J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():209-11. PubMed ID: 11820612
[TBL] [Abstract][Full Text] [Related]
9. Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations.
Lupi A; Tenni R; Rossi A; Cetta G; Forlino A
Amino Acids; 2008 Nov; 35(4):739-52. PubMed ID: 18340504
[TBL] [Abstract][Full Text] [Related]
10. Prolidase-activated prodrug for cancer chemotherapy cytotoxic activity of proline analogue of chlorambucil in breast cancer MCF-7 cells.
Bielawska A; Bielawski K; Chrzanowski K; Wołczyński S
Farmaco; 2000; 55(11-12):736-41. PubMed ID: 11204951
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity and effect on collagen biosynthesis of proline analogue of melphalan as a prolidase-convertible prodrug in cultured human skin fibroblasts.
Chrzanowski K; Bielawska A; Bielawski K; Wołczyński S; Pałka J
Farmaco; 2001 Sep; 56(9):701-6. PubMed ID: 11680815
[TBL] [Abstract][Full Text] [Related]
12. Proline prodrug of melphalan targeted to prolidase, a prodrug activating enzyme overexpressed in melanoma.
Mittal S; Song X; Vig BS; Amidon GL
Pharm Res; 2007 Jul; 24(7):1290-8. PubMed ID: 17377743
[TBL] [Abstract][Full Text] [Related]
13. Acetylsalicylic acid as a potential regulator of prolidase-convertible pro-drugs in control and neoplastic cells.
Chrzanowski K; Bielawska A; Bielawski K; Pałka J; Wołczyński S
Farmaco; 2004 Sep; 59(9):679-84. PubMed ID: 15337432
[TBL] [Abstract][Full Text] [Related]
14. Prolidase isoenzymes in the rat: their organ distribution, developmental change and specific inhibitors.
Liu G; Nakayama K; Awata S; Tang S; Kitaoka N; Manabe M; Kodama H
Pediatr Res; 2007 Jul; 62(1):54-9. PubMed ID: 17515839
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of prolidase activity by nickel causes decreased growth of proline auxotrophic CHO cells.
Miltyk W; Surazynski A; Kasprzak KS; Fivash MJ; Buzard GS; Phang JM
J Cell Biochem; 2005 Apr; 94(6):1210-7. PubMed ID: 15696600
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule based delivery systems for alkylating antineoplastic compounds.
Bielawski K; Bielawska A
ChemMedChem; 2008 Apr; 3(4):536-42. PubMed ID: 18157855
[TBL] [Abstract][Full Text] [Related]
17. Development of methotrexate proline prodrug to overcome resistance by MDA-MB-231 cells.
Wu Z; Shah A; Patel N; Yuan X
Bioorg Med Chem Lett; 2010 Sep; 20(17):5108-12. PubMed ID: 20674353
[TBL] [Abstract][Full Text] [Related]
18. L-proline analogues of anthraquinone-2-carboxylic acid: cytotoxic activity in breast cancer MCF-7 cells and inhibitory activity against topoisomerase I and II.
Bielawska A; Kosk K; Bielawski K
Pol J Pharmacol; 2001; 53(3):283-7. PubMed ID: 11785929
[TBL] [Abstract][Full Text] [Related]
19. The role of prolidase as an enzyme participating in the metabolism of collagen.
Pałka JA
Rocz Akad Med Bialymst; 1996; 41(2):149-60. PubMed ID: 9020526
[TBL] [Abstract][Full Text] [Related]
20. Activity of prolidase isoenzymes in the rat brain: subcellular and regional distribution during development.
Chi H; Lu J; Liu G; Tong J; Nakayama K; Yamashita K; Kitaoka N; Kodama H
Brain Res; 2009 Dec; 1303():8-14. PubMed ID: 19782660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]